{"id":55630,"date":"2023-04-10T12:06:25","date_gmt":"2023-04-10T10:06:25","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\/"},"modified":"2023-04-10T12:06:25","modified_gmt":"2023-04-10T10:06:25","slug":"nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\/","title":{"rendered":"NanoString to Release First Quarter 2023 Operating Results and Host Conference Call on Wednesday, May 3, 2023"},"content":{"rendered":"
\n

SEATTLE–(BUSINESS WIRE)–NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report first quarter 2023 operating results after the close of the market on Wednesday, May 3, 2023. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.<\/p>\n

<\/a><\/p>\n

\nInvestors and other interested parties should register for the conference call in advance by visiting https:\/\/events.q4inc.com\/attendee\/850976054<\/a>. Following registration, an email confirmation will be sent that includes dial-in details and unique conference call codes for entry. Registration is open throughout the call but to ensure connection for the full call, registration in advance is recommended.<\/p>\n

\nThe link to the webcast and audio replay will be made available at the Investor Relations website: nanostring.com<\/a>.<\/p>\n

\nA replay of the call will be available beginning May 3, 2023, at 7:30pm ET through midnight on May 17, 2023. To access the replay, dial (866) 813-9403 or (929) 458-6194 and reference Conference ID: 573494. The webcast will also be available on the Company\u2019s website for one year following the completion of the call.<\/p>\n

\nAbout NanoString<\/b><\/p>\n

\nNanoString Technologies, a leader in spatial biology<\/a>, offers an ecosystem of innovative discovery and translational research solutions, empowering our customers to map the universe of biology. The GeoMx\u00ae Digital Spatial Profiler, cited in approximately 200 peer-reviewed publications, is a flexible and consistent solution combining the power of whole tissue imaging with gene expression and protein data for spatial whole transcriptomics and proteomics from one FFPE slide. The CosMx\u2122 Spatial Molecular Imager is an FFPE-compatible, single-cell imaging<\/a> platform powered by spatial multiomics enabling researchers to map single cells in their native environments to extract deep biological insights and novel discoveries from one experiment. The AtoMx\u2122 Spatial Informatics Platform is a cloud-based informatics solution with advanced analytics and global collaboration capabilities, enabling powerful spatial biology insights anytime, anywhere. At the foundation of our research tools is our nCounter\u00ae Analysis System, cited in approximately 6,500 peer-reviewed publications, which offers a secure way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision.<\/p>\n

\nFor more information, please visit www.nanostring.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nDoug Farrell
\n
Vice President, Investor Relations & Corporate Communications
\n
dfarrell@nanostring.com<\/a>
Phone: 206-602-1768<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SEATTLE–(BUSINESS WIRE)–NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report first quarter 2023 operating results after the close of the market on Wednesday, May 3, 2023. Company management will host a conference call beginning at 4:30pm ET to discuss those results … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55630","6":"format-standard","7":"category-industry"},"yoast_head":"\nNanoString to Release First Quarter 2023 Operating Results and Host Conference Call on Wednesday, May 3, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NanoString to Release First Quarter 2023 Operating Results and Host Conference Call on Wednesday, May 3, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SEATTLE–(BUSINESS WIRE)–NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report first quarter 2023 operating results after the close of the market on Wednesday, May 3, 2023. Company management will host a conference call beginning at 4:30pm ET to discuss those results ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-10T10:06:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230410005105\/en\/1070856\/21\/4891105_NSTG_logo_for_Yahoo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"NanoString to Release First Quarter 2023 Operating Results and Host Conference Call on Wednesday, May 3, 2023\",\"datePublished\":\"2023-04-10T10:06:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\\\/\"},\"wordCount\":395,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230410005105\\\/en\\\/1070856\\\/21\\\/4891105_NSTG_logo_for_Yahoo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\\\/\",\"name\":\"NanoString to Release First Quarter 2023 Operating Results and Host Conference Call on Wednesday, May 3, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230410005105\\\/en\\\/1070856\\\/21\\\/4891105_NSTG_logo_for_Yahoo.jpg\",\"datePublished\":\"2023-04-10T10:06:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230410005105\\\/en\\\/1070856\\\/21\\\/4891105_NSTG_logo_for_Yahoo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230410005105\\\/en\\\/1070856\\\/21\\\/4891105_NSTG_logo_for_Yahoo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NanoString to Release First Quarter 2023 Operating Results and Host Conference Call on Wednesday, May 3, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NanoString to Release First Quarter 2023 Operating Results and Host Conference Call on Wednesday, May 3, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\/","og_locale":"en_US","og_type":"article","og_title":"NanoString to Release First Quarter 2023 Operating Results and Host Conference Call on Wednesday, May 3, 2023 - Pharma Trend","og_description":"SEATTLE–(BUSINESS WIRE)–NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report first quarter 2023 operating results after the close of the market on Wednesday, May 3, 2023. Company management will host a conference call beginning at 4:30pm ET to discuss those results ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-10T10:06:25+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230410005105\/en\/1070856\/21\/4891105_NSTG_logo_for_Yahoo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"NanoString to Release First Quarter 2023 Operating Results and Host Conference Call on Wednesday, May 3, 2023","datePublished":"2023-04-10T10:06:25+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\/"},"wordCount":395,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230410005105\/en\/1070856\/21\/4891105_NSTG_logo_for_Yahoo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\/","url":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\/","name":"NanoString to Release First Quarter 2023 Operating Results and Host Conference Call on Wednesday, May 3, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230410005105\/en\/1070856\/21\/4891105_NSTG_logo_for_Yahoo.jpg","datePublished":"2023-04-10T10:06:25+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230410005105\/en\/1070856\/21\/4891105_NSTG_logo_for_Yahoo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230410005105\/en\/1070856\/21\/4891105_NSTG_logo_for_Yahoo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-first-quarter-2023-operating-results-and-host-conference-call-on-wednesday-may-3-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"NanoString to Release First Quarter 2023 Operating Results and Host Conference Call on Wednesday, May 3, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55630","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55630"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55630\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55630"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55630"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55630"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}